Nicolas Torno

Title: Inventor Profile: Nicolas Torno

Introduction

Nicolas Torno is a prominent inventor based in Paris, France. With a strong focus on virology and cancer research, he holds two significant patents that contribute to understanding the impact of papillomavirus on cancer progression. His innovative work has implications for developing diagnostic tools and methods for early cancer detection.

Latest Patents

Nicolas Torno’s latest patents include "Broad range gene and genotype papillomavirus transcriptome as a biomarker of papillomavirus-associated cancer stages." This invention provides compositions, kits, and methods for determining the levels of expression of human polyoma or papillomavirus species and RNA transcripts. These expression levels can be crucial for the prognosis of the risk of developing virally-induced cancers. Notably, the ratio (R) between early and late transcripts serves as an indicator of HPV infections associated with a higher risk of developing genital neoplasia and cancer.

Career Highlights

Throughout his career, Nicolas has contributed to significant advancements in the field of virology while working with esteemed institutions such as the Institut Pasteur and the Ecole Nationale Veterinaire D'Alfort. His research and innovations have paved the way for more effective strategies in cancer prevention and risk assessment related to viral infections.

Collaborations

Nicolas Torno has collaborated with notable experts in the field, including Marc Eloit and Jean Deregnaucourt. These partnerships have enhanced his research insights and fostered the development of his groundbreaking inventions.

Conclusion

Nicolas Torno's contributions to the understanding of papillomavirus and its relation to cancer underscore his importance as an inventor in the scientific community. His patents hold great promise in improving cancer prognosis and early detection methods, reflecting his commitment to innovative research in virology and public health.